FDA green-lights Toshibas dose-reduction technology

green light - 194.77 Kb
The FDA has cleared Toshiba America Medical Systems’ Adaptive Iterative Dose Reduction 3D (AIDR 3D) dose-reduction technology.

AIDR 3D is Toshiba’s third-generation iterative dose reconstruction software that reduces radiation dose compared with conventional scanning. It comprises an algorithm designed to work in both the raw data and image data space, Tustin, Calif.-based Toshiba said.

The company will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion One, Aquilion Premium and Aquilion Prime CT customers.

AIDR 3D can be integrated with SureExposure 3D, a software that seeks to calculate the minimum radiation exposure required. SureExposure 3D adjusts the dose for each patient based on a pre-set, targeted level of image quality.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.